These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 9541335)

  • 1. Substance abuse in schizophrenia: a review.
    Buckley PF
    J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
    Green AI
    J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antipsychotic agents: emerging clinical profiles.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine use in a forensic population in a New South Wales prison hospital.
    Martin A; O'Driscoll C; Samuels A
    Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine for substance-abusing schizophrenic patients.
    Tsuang JW; Eckman TE; Shaner A; Marder SR
    Am J Psychiatry; 1999 Jul; 156(7):1119-20. PubMed ID: 10401473
    [No Abstract]   [Full Text] [Related]  

  • 10. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of schizophrenia with substance use disorders.
    Lybrand J; Caroff S
    Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse and clozapine treatment.
    Buckley P; Thompson PA; Way L; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():114-6. PubMed ID: 7961553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
    Arranz B; Garriga M; García-Rizo C; San L
    Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
    Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
    J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?
    Awad AG
    J Psychopharmacol; 2012 Jul; 26(7):953-7. PubMed ID: 22170735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
    Advokat C
    Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid schizophrenia and substance abuse.
    Green AI; Brown ES
    J Clin Psychiatry; 2006 Sep; 67(9):e08. PubMed ID: 17081075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of clozapine discontinuation in patients with schizophrenia.
    Krivoy A; Malka L; Fischel T; Weizman A; Valevski A
    Int Clin Psychopharmacol; 2011 Nov; 26(6):311-5. PubMed ID: 21849905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dual diagnosis disorders.
    Murthy P; Chand P
    Curr Opin Psychiatry; 2012 May; 25(3):194-200. PubMed ID: 22395768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.